Adverse drug reactions (ADRs) are monitored through pharmacovigilance systems, which collect and analyze data on drug-related adverse events. These systems include spontaneous reporting databases, electronic health records, and patient registries. Epidemiologists analyze this data to identify patterns and trends, which can lead to the identification of new ADRs and the implementation of risk mitigation strategies.
